Cantel Medical (CMD) Reports In-Line Q1 EPS

Cantel Medical (NYSE: CMD) reported Q1 EPS of $0.62, in-line with the analyst estimate of $0.62. Revenue for the quarter came in at $225.6 million versus the consensus estimate of $228.16 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c